Financial reports
10-K
2023 FY
Annual report
27 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
24 Jul 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-K/A
2021 FY
Annual report (amended)
23 Aug 22
Current reports
8-K
Smartkem Reports Fourth Quarter and Full Year 2023 Financial Results
28 Mar 24
8-K
Unregistered Sales of Equity Securities
28 Feb 24
8-K
Entry into a Material Definitive Agreement
29 Jan 24
8-K
Smartkem, Inc. Appoints Melisa a. Denis to the Board of Directors
28 Nov 23
8-K
SMARTKEM, INC. ANNOUNCES 1-for-35 REVERSE STOCK SPLIT
20 Sep 23
8-K
Departure of Directors or Certain Officers
8 Sep 23
8-K
Departure of Directors or Certain Officers
28 Aug 23
8-K
Sri Peruvemba Joins Smartkem Board of Directors
18 Jul 23
8-K
Smartkem, Inc. Receives Additional $2.0 Million In Final Closing of Private Placement
23 Jun 23
8-K
Smartkem, Inc. Receives $12.2 Million In Initial Closing of Private Placement
15 Jun 23
Registration and prospectus
424B3
Prospectus supplement
17 Apr 24
424B3
Prospectus supplement
17 Apr 24
S-8
Registration of securities for employees
11 Apr 24
S-1
IPO registration
11 Apr 24
POS AM
Prospectus update (post-effective amendment)
11 Apr 24
424B3
Prospectus supplement
10 Apr 24
POS AM
Prospectus update (post-effective amendment)
5 Apr 24
D
$347.50 k in equity, sold $347.50 k, 1 investor
18 Mar 24
424B3
Prospectus supplement
13 Nov 23
424B3
Prospectus supplement
13 Nov 23
Other
EFFECT
Notice of effectiveness
18 Apr 24
EFFECT
Notice of effectiveness
18 Apr 24
EFFECT
Notice of effectiveness
10 Apr 24
EFFECT
Notice of effectiveness
31 Jul 23
UPLOAD
Letter from SEC
26 Jul 23
CORRESP
Correspondence with SEC
25 Jul 23
EFFECT
Notice of effectiveness
11 Apr 23
EFFECT
Notice of effectiveness
8 Sep 22
EFFECT
Notice of effectiveness
8 Sep 22
EFFECT
Notice of effectiveness
18 Apr 22